Page 11 of 12
Bioconjugate Chemistry
modifications at the 3' and 4' positions of doxorubicin on the
drug ability to trap topoisomerase II and to overcome multi-
drug resistance. Mol Pharmacol. 45, 5, 908-915.
pH-sensitive doxorubicin-conjugated prodrug micelles with
1
2
3
4
5
6
7
8
9
33. Gallois, L., Fiallo, M., Garnier-Suillerot, A. (1998) Compari-
son of the interaction of doxorubicin, daunorubicin, idarubicin
and idarubicinol with large unilamellar vesicles: Circular di-
chroism study. Biochimica et Biophysica Acta (BBA) -
18. Lee, E.S., Gao, Z., Kim, D., Park, K., Kwon, I.C., Bae, Y.H.
(2008) Super pH-sensitive multifunctional polymeric mi-
celle for tumor pHe specific TAT exposure and multidrug
resistance.
J
Control Release. 129, 3, 228–236.
Biomembranes
1370.
1,
31-40.
19. Wang, Y., Li, L., Jiang, W., Yang, Z., Zhang, Z. (2006) Syn-
thesis and preliminary antitumor activity evaluation of a
DHA and doxorubicin conjugate. Bioorg Med Chem Lett.
20. Swietach, P., Vaughan-Jones, R.D., Harris, A.L., Hulikova,
A. (2014) The chemistry, physiology and pathology of pH in
cancer. Philosophical Transactions of the Royal Society B:
Biological Sciences. 369, 1638, 2013009-2013018.
34. Nikiforov, T.T., Beechem, J.M. (2006) Development of ho-
mogeneous binding assays based on fluorescence resonance
energy transfer between quantum dots and Alexa Fluor fluor-
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
ophores.
Anal
Biochem.
357,
1,
68-76.
35. Hanulia, T., Inami, W., Ono, A., Kawata, Y. (2018) Fluores-
cence life-time measurement excited with ultraviolet surface
plasmon resonance. Optics Communications. 427, 266- 270,
doi.org/10.1016/j.optcom.2018.06.069.
36. Singharoy, D., Chowdhury, S., Mati, S.S., Ghosh, S. , Chatt,
P. (2017) Electron Transfer Switching Mechanism of a Naph-
thalimide Derivative with its Solvatochromic Behaviour An
Experimental and Theoretical Study with In Cell Investiga-
tions. Chem. Eur. J. 23, 16516–16524.
37. Wei, Y., Liao, R., Mahmood, A. A., Xu, H., Zhou, Q. (2017)
pH-responsive pHLIP (pH low insertion peptide) nanoclusters
of super-paramagnetic iron oxide nanoparticles as a tumor-se-
lective MRI con-trast agent. Acta Biomaterialia. 55, 194-
203. https://doi: 10.1016/j.actbio.2017.03.046.
38. Chhikara, B. S., St. Jean, N., Mandal, D., Kumar, A., & Pa-
rang, K. (2011) Fatty acyl amide derivatives of doxorubicin:
Synthesis and in vitro anticancer activities. European Journal
21. Majumdar, P., Bathula, C., Basu, S.M., Das, S.K., Agarwal,
R., Hati, S., Singh, A., Sen, S., Das, B.B. (2015) Design, syn-
thesis and evaluation of thiohydantoin derivatives as potent
topoisomerase I (Top1) inhibitors with anticancer activity. Eur
J
Med
Chem,
102.
540-551.
22. Chang, W.J., Kulkarni, M. V., Sun C.M. (2006) Traceless and
Stere- oselective Synthesis of Tetrahydro-β-carbolinethiohy-
dantoins by Microwave Irradiation. J. Comb. Chem. 8, 141-
23. Roué, N., Bergman, J. (1999) Synthesis of the marine alkaloid
leucettamine
B.
Tetrahedron.
55,
14729-14738.
24. Bader, J., Salameh, A.B., Angeles, P. M., Francisco, de Cór-
doba J.F., Gasch C. (2006) Stereocontrolled synthesis of thio-
hydantoin spironucleosides from sugar spiroacetals. Tetrahe-
25. Beloglazkina, E. K., Majouga, A. G., Romashkina, R. B., Zyk,
N. V. (2006) A novel catalyst for alkene epoxidation: a poly-
mer-supported CoIILCl2 {L = 2-(alkylthio)-3-phenyl-5-(pyr-
of
Medicinal
Chemistry.
46,
6,
2037-2042.
39. Legigan, T., Clarhaut, J., Tranoy‐Opalinski, I., Monvoisin,
A., Renoux, B., Thomas, M., Le Pape, A., Lerondel, S., Papot,
S. (2012) The First Generation of β‐Galactosidase‐Responsive
Prodrugs Designed for the Selective Treatment of Solid Tu-
mors in Prodrug Monotherapy. Angew. Chem. Int. Ed. 51,
11606-11610. https://doi: 10.1002/anie.201204935
40. Hassan, F., El-Hiti, G. A., Abd-Allateef, M., & Yousif, E.
(2017) Cytotoxicity anticancer activities of anastrozole
against breast, liver hepatocellular, and prostate cancer cells.
idine-2-ylmethylene)-
complex. Tetrahedron.
3,5-dihydro-4H-imidazole-4-one}
47, 2957-2959.
26. Kuznetsova, O., Antipin, R. L., Udina, A. V., Krasnovskaya,
O. O., Beloglazkina, E. K., Terenin, V. I., Koteliansky, V. E.,
Zyk, N. V., Majouga, A. G. (2016) An Improved Protocol for
Synthesis of 3‐Substituted 5‐Arylidene‐2‐thiohydantoins:
Two‐step Procedure Alternative to Classical Methods. J. Het-
Saudi
Medical
Journal.
38,
4,
359–365.
41. Hematyar, M., Soleimani, M., Es-haghi, A., Rezaei Mokar-
ram, A. (2018) Synergistic co-delivery of doxorubicin and
melittin using functionalized magnetic nanoparticles for can-
cer treatment: loading and in vitro release study by LC–
MS/MS. Artificial Cells, Nanomedicine, and Biotechnology.
19, 1-10. https://doi: 10.1080/21691401.2018.1536063.
42. Kleeberger., Rottinger M. E. (1993) Effect of pH and moder-
ate hyperthermia on doxorubicin, epirubicin and aclacinomy-
cin A cytotoxicity for Chinese hamster ovary cells. Cancer
erocyclic
Chem.
53,
1570-1577,
27. Tripathi, L. (2011) Design & synthesis of N'-[substituted] pyr-
idine-4- carbohydrazides as potential anticonvulsant agents.
Eur.
J.
Med.
Chem.
46,
2,
509-518.
28. Finnerup, N.B. (2015) Pharmacotherapy for neuropathic pain
in adults: a systematic review and meta-analysis. The Lancet.
29. Shorvon, S. D. (2009). Drug treatment of epilepsy in the cen-
tury of the ILAE: The second 50 years, 1959-2009. Epilep-
30. John, R. Green, L., Miller, H., Patsy, D., Burnett, A., Ward,
A. (1969) Clinical evaluation of albutoin. Neurology. 19,
12, 1207-1215. DOI: 10.1212/WNL.19.12.1207
31. Bridewell, D.J., Finlay, G.J., Baguley, B.C. (1997) Differen-
tial actions of aclarubicin and doxorubicin: the role of topoi-
somerase I. Oncol Res. 9, 535-42.
32. Capranico, G., Supino, R., Binaschi, M., Capolongo, L.,
Grandi, M. S, Zunino, F. (1994) Influence of structural
43. Nitiss, JL. (2009) Targeting DNA topoisomerase II in cancer
chemotherapy. Nat Rev Cancer. 9, 5, 338-350.
(2018) Doxorubicin-conjugated dexamethasone induced
MCF-7 apoptosis without entering the nucleus and able to
45. Stewart, J.P. (2007) Optimization of parameters for
10
ACS Paragon Plus Environment